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British Cardiovascular Society Young Investigator Award 2019
Donna Joanne Page,   1,2 Naveed Akbar,3 Sonali Munshaw,3 Betty Raman3
The four finalists for the 2019 British 
Cardiovascular Society (BCS) Young 
Investigator Award (YIA) were selected 
from a competitive pool of young 
researchers. At the BCS meeting in 
Manchester last June, each finalist gave a 
10 min oral presentation, followed by 
questions from a panel of independent 
judges. All finalists were guests of the BCS 
at the Society’s Annual Dinner, and first 
prize was awarded to Donna Page and 
presented by Dr Simon Ray, BCS 
President.
The details of the four YIA finalists and 
their academic training and interests can 
be seen below. We look forward to seeing 
new investigators and ideas at next year’s 
meeting and encourage all those training 
in cardiovascular research to submit their 
best research to this competition.
Winner
Dr Donna J Page
Identification of the major genetic 
contributors to tetralogy of Fallot
Dr Donna J Page is a Lecturer in Health-
care Science at Manchester Metropolitan 
University and an honorary Postdoctoral 
Research Associate at the University of 
Manchester(figure 1). She completed her 
PhD at the University of Manchester in 
the area of Cardiovascular Development 
with Dr Shane Herbert. Specifically, her 
work focused on the molecular control 
of blood vessel development using 
the zebrafish embryo model. Donna 
continued her postdoctoral studies at 
the University of Manchester in the 
area of Cardiovascular Genetics with 
Professor Bernard Keavney. The focus of 
her research is the genetics of congenital 
heart disease (CHD), the most common 
birth abnormality worldwide.
Dr Page’s current research aims to 
delineate the causes of non-syndromic 
tetralogy of Fallot (TOF), the most 
common, cyanotic CHD subtype. Her 
recent work with the Keavney group 
led to the identification of two genes, 
NOTCH1 and FLT4, as the major genetic 
contributors to non-syndromic TOF. For 
her contribution to this work, Donna 
was awarded the British Cardiovascular 
Society Young Investigator of the Year 
(2019). Donna continues to work closely 
with the Keavney group and her current 
focus is on understanding the functional 
impact of patient mutations in a number 
of novel TOF candidate genes and their 
contribution to the development of 
CHD.
runners-uP
Dr naveed Akbar
Endothelial cell-derived extracellular vesicles 
mediate neutrophil deployment from the 
spleen following acute myocardial infarction
Dr Naveed Akbar is a senior post-
doctoral scientist and Fulford Junior 
Research Fellow (Somerville College) 
in the Division of Cardiovascular Medi-
cine at the Oxford University (figure 2). 
Dr Akbar obtained a BSc (hons) in 
Human Biology before completing an 
MSc by research in Biomedical Sciences, 
where he developed an interest in 
vascular biology and undertook inter-
disciplinary training to synthesise and 
fabricate nanoparticles for vascular 
targeting. Dr Akbar went on to obtain 
his PhD in Medicine and Therapeutics 
at the University of Dundee, Scotland, 
where he investigated the role of innate 
immune signalling in vascular inflam-
mation using in vivo imaging.
Dr Akbar’s current research investi-
gates the role of extracellular vesicles 
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Figure 4 Dr Betty Raman
in inflammation. Extracellular vesicles 
are small membrane enclosed particles 
that carry protein and genetic material. 
They can be produced, released and 
taken up by cells of the same origin or 
cells of different origin. Dr Akbar has 
shown that the number of extracel-
lular vesicles rises in peripheral blood 
following acute myocardial infarction 
through enrichment of endothelial cell 
derived extracellular vesicles that can 
alter the cellular status of immune cells 
to mediate cell movement. Extracel-
lular vesicles may provide diagnostic 
potential to better stratify patients for 
treatment following ischaemic injury 
and as tools for therapeutic targeting.
Dr sonali Munshaw
Thymosin β4—a novel regulator of low 
density lipoprotein receptor related protein 1 
(LRP1) in vascular disease
Dr Munshaw obtained an MSc 
in Biochemistry at the University 
of Madras, India, ranking second 
(figure 3). She joined the Experi-
mental Radiation Therapeutic Group 
at the University of Oxford to study 
radiopharmaceutical treatment of 
Breast Cancer and subsequently joined 
Nicola Smarts’ Group where she had 
the opportunity to explore the fields 
of Cardiac Regeneration and Vascular 
Protection. Dr Munshaw’s increasing 
interest in the molecular mechanisms of 
cardiovascular disease motivated her to 
undertake a PhD in this field. She was 
awarded a prestigious MRC student-
ship and has presented work within the 
UK and abroad and has won awards 
including runner up in the BCS Young 
Investigator Award 2019.
Dr Munshaw is currently exploring 
the therapeutic potential of thymosin 
β4 in aortic diseases and its role in 
regulating the extracellular matrix to 
protect the vasculature. We know that 
injury-induced growth factors stimu-
late a phenotypic switching of vascular 
smooth muscle cells and chronic de-dif-
ferentiation. This leads to vascular 
thickening and stiffness, exacerbates 
inflammation and promotes atheroscle-
rotic lesion development and suscep-
tibility to abdominal aortic aneurysm. 
Studies on vascular development in the 
embryo have provided novel insights 
into mechanisms that are important 
for maintenance of vessel stability 
throughout adult life. We have char-
acterised a key regulatory pathway for 
maintaining vascular health which may 
enable us to identify novel therapeutic 
targets for modulation of vascular 
stability and disease progression.
Dr Betty raman
Stress myocardial oxygenation and not 
perfusion reserve determines arrhythmic 
risk in hypertrophic cardiomyopathy: 
insights from a novel oxygen-sensitive CMR 
approach
After specialising in internal medicine 
and cardiology in Australia (2015), Dr 
Betty Raman undertook her doctoral 
studies at the University of Oxford 
investigating the role of multiparametric 
cardiac MRI (CMR) in hypertrophic 
cardiomyopathy (HCM)(figure 4). Dr 
Raman’s work has received considerable 
recognition both nationally and inter-
nationally, having presented as a young 
investigator finalist in five meetings. 
Dr Raman has also been awarded many 
competitive scholarships including the 
National Heart Foundation of Australia 
Scholarship, Cardiac Society of Australia 
and New Zealand Research Scholarship 
and NIHR Oxford Biomedical Research 
Centre Doctoral Fellowship. She has 
over 50 published conference abstracts 
and original articles (>15 publications) 
in peer-reviewed journals.
Dr Raman’s work has focussed on 
trying to improve risk stratification in 
patients with HCM, the number one 
cause of sudden cardiac death in the 
young. Dr Raman and her colleagues 
have discovered a way to provide a 
more precise assessment of myocardial 
oxygenation using a technique called 
blood oxygen level dependent CMR. 
Using this approach, she showed that it 
is not only possible to detect subclinical 
changes in oxygen sensitive signal within 
the heart but also visualise this on CMR. 
She further demonstrated that patients 
with HCM with impaired stress oxygen-
ation were at a threefold increased risk 
of life-threatening arrhythmias.
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